SELECT MEDICAL CORP FILES (8-K) Disclosing Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits
(Edgar Glimpses Via Acquire Media NewsEdge)
Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Effective January 1, 2014, the Boards of Directors (the "Boards") of Select
Medical Holdings Corporation, a Delaware corporation ("Holdings"), and Select
Medical Corporation, a Delaware corporation ("Select"), appointed David S.
Chernow to serve as President and Chief Executive Officer of Holdings and
Mr. Chernow, 56, has served as President of Holdings and Select since
September 2010. He has held various additional executive officer titles with
Holdings and Select since September 2010. He previously served on Holdings' and
Select's Boards of Directors from August 2005 to September 2010. From May 2007
to February 2010, Mr. Chernow served as the President and Chief Executive
Officer of Oncure Medical Corp. He will continue to report directly to
Mr. Robert A. Ortenzio.
Robert A. Ortenzio, 56, has been appointed to serve as Holdings' and Select's
Executive Chairman and Co-Founder effective on January 1, 2014. Mr. Ortenzio
has served as Holdings' and Select's Chief Executive Officer since
February 2005. He will continue to serve as a member of Holdings' and Select's
Boards of Directors. In his role as Executive Chairman and Co-Founder,
Mr. Ortenzio will continue to focus on overall company strategy, mergers and
acquisitions and government and investor relations. Mr. Ortenzio is the son of
Mr. Rocco A. Ortenzio.
Rocco A. Ortenzio, 81, has been appointed to serve as Holdings' and Select's
Vice Chairman and Co-Founder effective on January 1, 2014. Mr. Ortenzio has
served as Holdings' and Select's Executive Chairman since February 2005. He
will continue to serve as a member of Holdings' and Select's Boards of
Directors. Mr. Ortenzio is the father of Mr. Robert A. Ortenzio.
Item 7.01 Regulation FD Disclosure.
On December 23, 2013, Holdings issued a press release announcing the matters
discussed above. A copy of the press release is attached as Exhibit 99.1 to this
The information in this report (including Exhibit 99.1) is being furnished
pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or
otherwise subject to the liabilities of that section, nor shall it be deemed to
be incorporated by reference in any filing under the Securities Act of 1933 or
the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
Exhibit Number Description
99.1 Press Release, dated December 23, 2013.
[ Back To Technology News's Homepage ]